Details for New Drug Application (NDA): 020313
✉ Email this page to a colleague
The generic ingredient in MIACALCIN is calcitonin salmon. There are fourteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
Summary for 020313
Tradename: | MIACALCIN |
Applicant: | Mylan Ireland Ltd |
Ingredient: | calcitonin salmon |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 17, 1995 | TE: | RLD: | Yes |
Expired US Patents for NDA 020313
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Ireland Ltd | MIACALCIN | calcitonin salmon | SPRAY, METERED;NASAL | 020313-002 | Aug 17, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan Ireland Ltd | MIACALCIN | calcitonin salmon | SPRAY, METERED;NASAL | 020313-002 | Aug 17, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription